SoundCure Inc, a tinnitus solution provider, has announced the launch of the Serenade Tinnitus Treatment System at the Association of Independent Hearing Healthcare Practitioners (AIHHP) spring conference in the UK.

Serenade was launched in the United States in April 2012, and is reportedly now offered by hundreds of Soundcure-opt
audiologists and hearing healthcare providers nationally. The UK launch marks the first formal commercial release outside the United States.

Serenade offers tinnitus sufferers potential relief using SoundCure’s proprietary S-Tones®, which are customized treatment sounds developed independently by hearing researchers at the University of California.

The handheld Serenade device is programmed in the clinician’s office for each individual patient according to his specific condition. Through Serenade’s earphones, the patient listens to therapeutic sounds designed to address the underlying neurological cause of tinnitus. Four different treatment sounds are available.

S-Tones are low frequency, amplitude modulated tones that are frequency pitch-matched to a patient’s unique tinnitus. According to Dr Fan-Gang Zeng, one of Serenade’s inventors, these modulated tones “keep the brain’s interest,” thus “reducing the perceived tinnitus sound and bringing relief.” In addition, S-Tones are intended to be “listened to at a volume that is lower than the patient’s tinnitus, reducing the sound burden,” said Zeng.

SoundCure CEO Bill Perry states, “We are proud and excited to make the Serenade technology and tinnitus management approach available to a wider audience, and look forward to being part of the solution for tinnitus sufferers in the UK.”

SOURCE: SoundCure Inc